Open Access
REVIEW
Recent updates on nano-phyto-formulations based therapeutic intervention for cancer treatment
ABHISHEK WAHI1, MAMTA BISHNOI2, NEHA RAINA1, MEGHNA AMRITA SINGH1, PIYUSH VERMA1, PIYUSH KUMAR GUPTA3,4, GINPREET KAUR5, HARDEEP SINGH TULI6,*, MADHU GUPTA1,*
1 Department of Pharmaceutics, School of Pharmaceutical Sciences, Delhi Pharmaceutical Sciences and Research University (DPSRU), Pushp Vihar, New Delhi,
110017, India
2 Department of Pharmaceutical Sciences, Gurugram University, Haryana, 122003, India
3 Department of Life Sciences, Sharda School of Basic Sciences and Research, Sharda University, Greater Noida, Uttar Pradesh, 201310, India
4 Department of Biotechnology, Graphic Era (Deemed to be University), Dehradun, Uttarakhand, 248002, India
5 Department of Pharmacology, Shobhaben Pratapbhai Patel School of Pharmacy & Technology Management, SVKM’s NMIMS, Vile Parle (West), Mumbai,
400056, India
6 Department of Bio-Sciences and Technology, Maharishi Markandeshwar Engineering College, Maharishi Markandeshwar (Deemed to be University), Mullana,
Ambala, 133207, India
* Corresponding Authors: Madhu Gupta, ; Hardeep Singh Tuli,
Oncology Research 2024, 32(1), 19-47. https://doi.org/10.32604/or.2023.042228
Received 23 May 2023; Accepted 27 July 2023; Issue published 15 November 2023
Abstract
Cancer is a leading cause of death globally, with limited treatment options and several limitations.
Chemotherapeutic agents often result in toxicity which long-term conventional treatment. Phytochemicals are natural
constituents that are more effective in treating various diseases with less toxicity than the chemotherapeutic agents
providing alternative therapeutic approaches to minimize the resistance. These phytoconstituents act in several ways
and deliver optimum effectiveness against cancer. Nevertheless, the effectiveness of phyto-formulations in the
management of cancers may be constrained due to challenges related to inadequate solubility, bioavailability, and
stability. Nanotechnology presents a promising avenue for transforming current cancer treatment methods through
the incorporation of phytochemicals into nanosystems, which possess a range of advantageous characteristics such as
biocompatibility, targeted and sustained release capabilities, and enhanced protective effects. This holds significant
potential for future advancements in cancer management. Herein, this review aims to provide intensive literature on
diverse nanocarriers, highlighting their applications as cargos for phytocompounds in cancer. Moreover, it offers an
overview of the current advancements in the respective field, emphasizing the characteristics that contribute to
favourable outcomes in both in vitro and in vivo settings. Lastly, clinical development and regulatory concerns are
also discussed to check on the transformation of the concept as a promising strategy for combination therapy of
phytochemicals and chemotherapeutics that could lead to cancer management in the future.
Graphical Abstract
Keywords
Cite This Article
APA Style
WAHI, A., BISHNOI, M., RAINA, N., SINGH, M.A., VERMA, P. et al. (2024). Recent updates on nano-phyto-formulations based therapeutic intervention for cancer treatment. Oncology Research, 32(1), 19-47. https://doi.org/10.32604/or.2023.042228
Vancouver Style
WAHI A, BISHNOI M, RAINA N, SINGH MA, VERMA P, GUPTA PK, et al. Recent updates on nano-phyto-formulations based therapeutic intervention for cancer treatment. Oncol Res. 2024;32(1):19-47 https://doi.org/10.32604/or.2023.042228
IEEE Style
A. WAHI et al., "Recent updates on nano-phyto-formulations based therapeutic intervention for cancer treatment," Oncol. Res., vol. 32, no. 1, pp. 19-47. 2024. https://doi.org/10.32604/or.2023.042228